Laos Healthcare Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Laos Healthcare Review.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on January 9, 2026

Jan. 9, 2026

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones

GlobeNewswire

Jan. 9, 2026

Peer-reviewed study demonstrates LEON’s FR-JET® modular mixer enables stable high-concentration mRNA-LNPs with enhanced in vivo activity

GlobeNewswire

Jan. 9, 2026

Attindas Hygiene Partners Expands European Position with Key Acquisition

GlobeNewswire

Jan. 9, 2026

Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies

GlobeNewswire

Jan. 9, 2026

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine

GlobeNewswire

Jan. 9, 2026

uniQure Announces Type A Meeting Scheduled with FDA

GlobeNewswire

Jan. 9, 2026

Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference

GlobeNewswire

Jan. 9, 2026

Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes

GlobeNewswire

Jan. 9, 2026

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 9, 2026

Avance Clinical to Showcase New Early Phase Center of Excellence at Biotech Showcase 2026

GlobeNewswire

Jan. 9, 2026

Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco

GlobeNewswire

Jan. 9, 2026

Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update

GlobeNewswire

Jan. 9, 2026

Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”

GlobeNewswire

Jan. 9, 2026

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026

GlobeNewswire

Jan. 9, 2026

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

GlobeNewswire

Jan. 9, 2026

RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026

GlobeNewswire

Jan. 9, 2026

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

GlobeNewswire

Jan. 9, 2026

Now Available: 1G Live Resin THCA Disposable By The Hemp Doctor

GlobeNewswire

Jan. 9, 2026

Alveus Therapeutics annoncerer serie A-financiering på 160 mio. USD til næste generations behandlinger mod fedme og stofskiftesygdomme

GlobeNewswire

Jan. 9, 2026

O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated

GlobeNewswire